title: Is strengthening the endothelial barrier a therapeutic strategy for Ebola?
authors.affiliation: Interdepartmental Division of Critical Care, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Niall C
authors.initials: NC
authors.lastname: Filewod
authors.affiliation: Interdepartmental Division of Critical Care, University of Toronto, Toronto, Ontario, Canada; Keenan Research Centre, St. Michael's Hospital, Toronto, Ontario, Canada. Electronic address: warren.lee@utoronto.ca.
authors.forename: Warren L
authors.initials: WL
authors.lastname: Lee
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use*; D005260:Female; D019142:Hemorrhagic Fever, Ebola / Q000188:drug therapy*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male
chemical_list: D057911:Angiotensin Receptor Antagonists; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors